Lv5
1448 积分 2024-06-07 加入
A multicenter, randomized, double-blinded, placebo-controlled phase III trial to evaluate efficacy and safety of picankibart in moderate-to-severe plaque psoriasis
6天前
已完结
Real‐World Effectiveness and Safety of Biologic Switches in Chinese Patients With Plaque Psoriasis: A Single‐Center Retrospective Study
6天前
已完结
Disease modification in psoriasis through early interleukin 17 inhibitor intervention: A retrospective cohort study
6天前
已完结
Psoriasis
7天前
已完结
Disclosing the Overall and Sex‐Related Disease Burden and Treatment Needs of Patients With Anogenital Psoriasis: Results From the Case–Control PsoGen Study
7天前
已完结
Long-term risk of incident psoriasis in patients with irritable bowel syndrome: a large-scale prospective cohort study
7天前
已完结
Molecular and Cellular Profiling of Scalp Psoriasis Reveals Differences and Similarities Compared to Skin Psoriasis
1个月前
已完结
Efficacy and safety of risankizumab in moderate-to-severe plaque psoriasis (UltIMMa-1 and UltIMMa-2): results from two double-blind, randomised, placebo-controlled and ustekinumab-controlled phase 3 trials
1个月前
已完结
Risankizumab compared with adalimumab in patients with moderate-to-severe plaque psoriasis (IMMvent): a randomised, double-blind, active-comparator-controlled phase 3 trial
1个月前
已完结
Psoriasis With Eczematous Features: A Retrospective Clinicopathologic Study
2个月前
已完结
皖公网安备34019202002308
